3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Conditions
Venous Thromboembolism
3
Neoplasms
2
Venous Thrombosis
1
Lung Neoplasms
1
Esophageal Neoplasms
1
Interventions
Dalteparin
10
apixaban
5
Tinzaparin
4
Enoxaparin
4
Heparin, Low-Molecular-Weight
3
edoxaban
2
bemiparin
2
abelacimab
2
Warfarin
2
MAA868
2
Fondaparinux
2
Dabigatran
2
reviparin
1
isoquercitrin
1
certoparin
1
calcium heparin
1
acarboxyprothrombin
1
Rosuvastatin Calcium
1
Rivaroxaban
1
Phenprocoumon
1
Nadroparin
1
Heparin
1
Educational Status
1
Acenocoumarol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thrombosis
×
Nadroparin
×
Classical hematology
×
Clear all
NCT01164046
2014-12-03
Longheva
University Medical Center Groningen
Phase 3
Terminated
56 enrolled